Review of osteoimmunology and the host response in endodontic and periodontal lesions

References

• Kakehashi S, Stanley HR, Fitzgerald RJ. The effects of surgical exposures of dental pulps in germ-free and conventional laboratory rats. Oral Surg Oral Med Oral Pathol. 1965; 20: 340–9.
   PubMedGoogle Scholar
• Ricucci D, Siqueira JF Jr, Bate AL, Pitt Ford TR. Histologic investigation of root canal-treated teeth with apical periodontitis: a retrospective study from twenty-four patients. J Endod. 2009; 35: 493–502.
   PubMed Web of Science ®Google Scholar
• Nair PN. Pathogenesis of apical periodontitis and the causes of endodontic failures. Crit Rev Oral Biol Med. 2004; 15: 348–81.
   PubMedGoogle Scholar
• Liapatas S, Nakou M, Rontogianni D. Inflammatory infiltrate of chronic periradicular lesions: an immunohistochemical study. Int Endod J. 2003; 36: 464–71.
   Web of Science ®Google Scholar
• Stashenko P, Wang C, Riley E, Wu Y, Ostroff G, Niederman R. Reduction of infection-stimulated peripical bone resorption by the biological response modifier PGG glucan. J Dent Res. 1995; 74: 323–30.
   Web of Science ®Google Scholar
• Graves D, Chen C, Douville C, Jiang Y. Interleukin-1 receptor signaling rather than that of tumor necrosis factor is critical in protecting the host from the severe consequences of a polymicrobe anaerobic infection. Infect Immun. 2000; 8: 4746–51.
   Web of Science ®Google Scholar
• Fukada SY, Silva TA, Saconato IF, Garlet GP, Avila-Campos MJ, Silva JS, et al.. iNOS-derived nitric oxide modulates infection-stimulated bone loss. J Dent Res. 2008; 87: 1155–9.
   Web of Science ®Google Scholar
• Jiang Y, Mehta C, Hsu T, Alsulaimani F. Bacteria induce osteoclastogenesis via an osteoblast-independent pathway. Infect Immun. 2002; 70: 3143–8.
   PubMed Web of Science ®Google Scholar
• Gilles J, Carnes D, Dallas M, Holt S, Bonewald L. Oral bone loss is increased in ovariectomized rats. J Endodon. 1997; 23: 419–22.
   Web of Science ®Google Scholar
• Hirao K, Yumoto H, Takahashi K, Mukai K, Nakanishi T, Matsuo T. Roles of TLR2, TLR4, NOD2, and NOD1 in pulp fibroblasts. J Dent Res. 2009; 88: 762–7.
   PubMed Web of Science ®Google Scholar
• Bar-Shavit Z. Taking a toll on the bones: regulation of bone metabolism by innate immune regulators. Autoimmunity. 2008; 41: 195–203.
   PubMed Web of Science ®Google Scholar
• Stashenko P, Yu SM, Wang CY. Kinetics of immune cell and bone resorptive responses to endodontic infections. J Endod. 1992; 18: 422–6.
   PubMed Web of Science ®Google Scholar
• Colic M, Gazivoda D, Vucevic D, Vasilijic S, Rudolf R, Lukic A. Proinflammatory and immunoregulatory mechanisms in periapical lesions. Mol Immunol. 2009; 47: 101–13.
   PubMed Web of Science ®Google Scholar
• Fukada SY, Silva TA, Garlet GP, Rosa AL, da Silva JS, Cunha FQ. Factors involved in the T helper type 1 and type 2 cell commitment and osteoclast regulation in inflammatory apical diseases. Oral Microbiol Immunol. 2009; 24: 25–31.
   PubMedGoogle Scholar
• Colic M, Gazivoda D, Vucevic D, Majstorovic I, Vasilijic S, Rudolf R, et al.. Regulatory T-cells in periapical lesions. J Dent Res. 2009; 88: 997–1002.
   Web of Science ®Google Scholar
• Teles R, Wang CY, Stashenko P. Increased susceptibility of RAG-2 SCID mice to dissemination of endodontic infections. Infect Immun. 1997; 65: 3781–7.
   Web of Science ®Google Scholar
• Tani N, Kuchiba K, Osada T, Watanabe Y, Umemoto T. Effect of T-cell deficiency on the formation of periapical lesions in mice: histological comparison between periapical lesion formation in BALB/c and BALB/c nu/nu mice. J Endod. 1995; 21: 195–9.
   Web of Science ®Google Scholar
• Wallstrom JB, Torabinejad M, Kettering J, McMillan P. Role of T cells in the pathogenesis of periapical lesions. A preliminary report. Oral Surg Oral Med Oral Pathol. 1993; 76: 213–8.
   Google Scholar
• De Rossi A, Rocha LB, Rossi MA. Interferon-gamma, interleukin-10, intercellular adhesion molecule-1, and chemokine receptor 5, but not interleukin-4, attenuate the development of periapical lesions. J Endod. 2008; 34: 31–8.
   PubMed Web of Science ®Google Scholar
• Menezes R, Garlet TP, Trombone AP, Repeke CE, Letra A, Granjeiro JM, et al.. The potential role of suppressors of cytokine signaling in the attenuation of inflammatory reaction and alveolar bone loss associated with apical periodontitis. J Endod. 2008; 34: 1480–4.
   Web of Science ®Google Scholar
• Alshwaimi E, Purcell P, Kawai T, Sasaki H, Oukka M, Campos-Neto A, et al.. Regulatory T cells in mouse periapical lesions. J Endod. 2009; 35: 1229–33.
   Web of Science ®Google Scholar
• McNicholas S, Torabinejad M, Blankenship J, Bakland L. The concentration of prostaglandin E2 in human periradicular lesions. J Endod. 1991; 17: 97–100.
   Web of Science ®Google Scholar
• Torbinejad M, Clagett J, Engel D. A cat model for the evaluation of mechanisms of bone resorption: induction of bone loss by simulated immune complexes and inhibition by indomethacin. Calcif Tissue Int. 1979; 29: 207–14.
   Web of Science ®Google Scholar
• Fouad AF. IL-1 alpha and TNF-alpha expression in early periapical lesions of normal and immunodeficient mice. J Dent Res. 1997; 76: 1548–54.
   Web of Science ®Google Scholar
• Tani-Ishii N, Wang CY, Stashenko P. Immunolocalization of bone-resorptive cytokines in rat pulp and periapical lesions following surgical pulp exposure. Oral Microbiol Immunol. 1995; 10: 213–9.
   Google Scholar
• Stashenko P, Wang CY, Tani-Ishii N, Yu SM. Pathogenesis of induced rat periapical lesions. Oral Surg Oral Med Oral Pathol. 1994; 78: 494–502.
   PubMedGoogle Scholar
• Wang C, Stashenko P. The role of interleukin-1 alpha in the pathogenesis of periapical bone destruction in a rat model system. Oral Microbiol Immunol. 1993; 8: 50–6.
   Google Scholar
• Takeichi O, Saito I, Tsurumachi T, Moro I, Saito T. Expression of inflammatory cytokine genes in vivo by human alveolar bone-derived polymorphonuclear leukocytes isolated from chronically inflamed sites of bone resorption. Calcif Tissue Int. 1996; 58: 244–8.
   Web of Science ®Google Scholar
• Walker KF, Lappin DF, Takahashi K, Hope J, Macdonald DG, Kinane DF. Cytokine expression in periapical granulation tissue as assessed by immunohistochemistry. Eur J Oral Sci. 2000; 108: 195–201.
   Web of Science ®Google Scholar
• Huang GT, Do M, Wingard M, Park JS, Chugal N. Effect of interleukin-6 deficiency on the formation of periapical lesions after pulp exposure in mice. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2001; 92: 83–8.
   PubMed Web of Science ®Google Scholar
• Yamasaki M, Kumazawa M, Kohsaka T, Nakamura H. Effect of methodtrexate-induced neutropenia on rat periapical lesion. Oral Surg Oral Med Oral Pathol. 1994; 77: 655–61.
   Google Scholar
• Huang GT, Potente AP, Kim JW, Chugal N, Zhang X. Increased interleukin-8 expression in inflamed human dental pulps. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1999; 88: 214–20.
   Web of Science ®Google Scholar
• Silva TA, Garlet GP, Fukada SY, Silva JS, Cunha FQ. Chemokines in oral inflammatory diseases: apical periodontitis and periodontal disease. J Dent Res. 2007; 86: 306–19.
   Web of Science ®Google Scholar
• Rahimi P, Wang C, Stashenko P, Lee S, Lorenzo J, Graves D. Monocyte chemoattractant prtein-1 expression and monocyte recruitment in osseous inflammation in the mouse. Endocrinology. 1995; 136: 2752–9.
   PubMed Web of Science ®Google Scholar
• Chae P, Im M, Gibson F, Jiang Y, Graves D. Mice lacking monocyte chemoattractant protein 1 have enhanced susceptibility to an interstitial polymicrobial infection due to impaired monocyte recruitment. Infect Immun. 2002; 70: 3164–9.
   Web of Science ®Google Scholar
• Garlet TP, Fukada SY, Saconato IF, Avila-Campos MJ, Silva TAD, Garlet GP, et al.. CCR2 deficiency results in increased osteolysis in experimental periapical lesions in mice. J Endod. 2010; 36: 244–50.
   PubMed Web of Science ®Google Scholar
• Menezes R, Garlet TP, Letra A, Bramante CM, Campanelli AP, Figueira Rde C, et al.. Differential patterns of receptor activator of nuclear factor kappa B ligand/osteoprotegerin expression in human periapical granulomas: possible association with progressive or stable nature of the lesions. J Endod. 2008; 34: 932–8.
   PubMed Web of Science ®Google Scholar
• Kawashima N, Suzuki N, Yang G, Ohi C, Okuhara S, Nakano-Kawanishi H, et al.. Kinetics of RANKL, RANK and OPG expressions in experimentally induced rat periapical lesions. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2007; 103: 707–11.
   PubMed Web of Science ®Google Scholar
• Paster BJ, Olsen I, Aas JA, Dewhirst FE. The breadth of bacterial diversity in the human periodontal pocket and other oral sites. Periodontol 2000. 2006; 42: 80–7.
   PubMed Web of Science ®Google Scholar
• Pihlstrom BL, Michalowicz BS, Johnson NW. Periodontal diseases. Lancet. 2005; 366: 1809–20.
   PubMed Web of Science ®Google Scholar
• Sakamoto M, Umeda M, Benno Y. Molecular analysis of human oral microbiota. J Periodontal Res. 2005; 40: 277–85.
   PubMed Web of Science ®Google Scholar
• Haffajee AD, Teles RP, Socransky SS. The effect of periodontal therapy on the composition of the subgingival microbiota. Periodontol 2000. 2006; 42: 219–58.
   PubMed Web of Science ®Google Scholar
• Fine DH, Kaplan JB, Kachlany SC, Schreiner HC. How we got attached to Actinobacillus actinomycetemcomitans: a model for infectious diseases. Periodontol 2000. 2006; 42: 114–57.
   Web of Science ®Google Scholar
• Assuma R, Oates T, Cochran D, Amar S, Graves D. IL-1 and TNF antagonists inhibit the inflammatory response and bone loss in experimental periodontitis. J Immunol. 1998; 160: 403–9.
   PubMed Web of Science ®Google Scholar
• Delima A, Spyros K, Amar S, Graves DT. Inflammation and tissue loss caused by periodontal pathogens is reduced by IL-1 antagonists. J Infect Dis. 2002; 186: 511–6.
   PubMed Web of Science ®Google Scholar
• Teng Y, Nguyen H, Gao X, Kong Y, Gorczynski R, Singh B, et al.. Functional human T-cell immunity and osteoprotegerin ligand control alveolar bone destruction in periodontal infection. J Clin Invest. 2000; 106: R59–67.
   PubMed Web of Science ®Google Scholar
• Baker P, Dixon M, Evans R, Dufour L, Johnson E, Roopenian D. CD4(+) T cells and the proinflammatory cytokines gamma interferon and interleukin-6 contribute to alveolar bone loss in mice. Infect Immun. 1999; 67: 2804–9.
   PubMed Web of Science ®Google Scholar
• Socransky SS, Haffajee AD, Goodson JM, Lindhe J. New concepts of destructive periodontal disease. J Clin Periodontol. 1984; 11: 21–32.
   PubMed Web of Science ®Google Scholar
• Cohen ME, Ralls SA. Distributions of periodontal attachment levels. Mathematical models and implications. J Periodontol. 1988; 59: 254–8.
   PubMed Web of Science ®Google Scholar
• Gilthorpe MS, Zamzuri AT, Griffiths GS, Maddick IH, Eaton KA, Johnson NW. Unification of the “burst” and “linear” theories of periodontal disease progression: a multilevel manifestation of the same phenomenon. J Dent Res. 2003; 82: 200–5.
   Web of Science ®Google Scholar
• Graves DT, Fine D, Teng YT, Van Dyke TE, Hajishengallis G. The use of rodent models to investigate host-bacteria interactions related to periodontal diseases. J Clin Periodontol. 2008; 35: 89–105.
   PubMed Web of Science ®Google Scholar
• Rovin S, Costich ER, Gordon HA. The influence of bacteria and irritation in the initiation of periodontal disease in germfree and conventional rats. J Periodontal Res. 1966; 1: 193–204.
   PubMedGoogle Scholar
• Mahanonda R, Pichyangkul S. Toll-like receptors and their role in periodontal health and disease. Periodontol 2000. 2007; 43: 41–55.
   PubMed Web of Science ®Google Scholar
• Gelani V, Fernandes AP, Gasparoto TH, Garlet TP, Cestari TM, Lima HR, et al.. The role of toll-like receptor 2 in the recognition of Aggregatibacter actinomycetemcomitans. J Periodontol. 2009; 80: 2010–9.
   PubMed Web of Science ®Google Scholar
• Lima HR, Gelani V, Fernandes AP, Gasparoto TH, Torres SA, Santos CF, et al.. The essential role of TLR4 in the control of Aggregatibacter actinomycetemcomitans infection in mice. J Clin Periodontol. 2010; 37: 248–54.
   Web of Science ®Google Scholar
• Uehara A, Takada H. Functional TLRs and NODs in human gingival fibroblasts. J Dent Res. 2007; 86: 249–54.
   Web of Science ®Google Scholar
• Williams R, Jeffcoat M, Kaplan M, Goldhaber P, Johnson H, Wechter W. Flurbiprofen: a potent inhibitor of alveolar bone resorption in beagles. Science. 1985; 227: 640–2.
   PubMed Web of Science ®Google Scholar
• Delima A, Oates T, Assuma R, Schwartz Z, Cochran D, Amar S, et al.. Soluble antagonists to interleukin-1 (IL-1) and tumor necrosis factor (TNF) inhibits loss of tissue attachment in experimental periodontitis. J Clin Periodontol. 2001; 28: 233–40.
   PubMed Web of Science ®Google Scholar
• Han X, Kawai T, Eastcott JW, Taubman MA. Bacterial-responsive B lymphocytes induce periodontal bone resorption. J Immunol. 2006; 176: 625–31.
   PubMed Web of Science ®Google Scholar
• Jin Q, Cirelli JA, Park CH, Sugai JV, Taba M Jr, Kostenuik PJ, et al.. RANKL inhibition through osteoprotegerin blocks bone loss in experimental periodontitis. J Periodontol. 2007; 78: 1300–8.
   PubMed Web of Science ®Google Scholar
• Graves D. Cytokines that promote periodontal tissue destruction. J Periodontol. 2008; 79: 1585–91.
   PubMed Web of Science ®Google Scholar
• Fracon RN, Teofilo JM, Satin RB, Lamano T. Prostaglandins and bone: potential risks and benefits related to the use of nonsteroidal anti-inflammatory drugs in clinical dentistry. J Oral Sci. 2008; 50: 247–52.
   Google Scholar
• Noguchi K, Ishikawa I. The roles of cyclooxygenase-2 and prostaglandin E2 in periodontal disease. Periodontol 2000. 2007; 43: 85–101.
   PubMed Web of Science ®Google Scholar
• Miyauchi M, Ijuhin N, Nikai H, Takata T, Ito H, Ogawa I. Effect of exogenously applied prostaglandin E2 on alveolar bone loss—histometric analysis. J Periodontol. 1992; 63: 405–11.
   Web of Science ®Google Scholar
• Pouliot M, Clish CB, Petasis NA, Van Dyke TE, Serhan CN. Lipoxin A(4) analogues inhibit leukocyte recruitment to Porphyromonas gingivalis: a role for cyclooxygenase-2 and lipoxins in periodontal disease. Biochemistry. 2000; 39: 4761–8.
   PubMed Web of Science ®Google Scholar
• Bezerra MM, de Lima V, Alencar VB, Vieira IB, Brito GA, Ribeiro RA, et al.. Selective cyclooxygenase-2 inhibition prevents alveolar bone loss in experimental periodontitis in rats. J Periodontol. 2000; 71: 1009–14.
   PubMed Web of Science ®Google Scholar
• Pinho Mde N, Pereira LB, de Souza SL, Palioto DB, Grisi MF, Novaes AB Jr, et al.. Short-term effect of COX-2 selective inhibitor as an adjunct for the treatment of periodontal disease: a clinical double-blind study in humans. Braz Dent J. 2008; 19: 323–8.
   Google Scholar
• Hasturk H, Kantarci A, Ohira T, Arita M, Ebrahimi N, Chiang N, et al.. RvE1 protects from local inflammation and osteoclast-mediated bone destruction in periodontitis. FASEB J. 2006; 20: 401–3.
   PubMed Web of Science ®Google Scholar
• Garlet GP, Cardoso CR, Silva TA, Ferreira BR, Avila-Campos MJ, Cunha FQ, et al.. Cytokine pattern determines the progression of experimental periodontal disease induced by Actinobacillus actinomycetemcomitans through the modulation of MMPs, RANKL, and their physiological inhibitors. Oral Microbiol Immunol. 2006; 21: 12–20.
   PubMedGoogle Scholar
• Hou LT, Liu CM, Liu BY, Lin SJ, Liao CS, Rossomando EF. Interleukin-1beta, clinical parameters and matched cellular-histopathologic changes of biopsied gingival tissue from periodontitis patients. J Periodontal Res. 2003; 38: 247–54.
   Web of Science ®Google Scholar
• Salvi GE, Brown CE, Fujihashi K, Kiyono H, Smith FW, Beck JD, et al.. Inflammatory mediators of the terminal dentition in adult and early onset periodontitis. J Periodontal Res. 1998; 33: 212–25.
   PubMed Web of Science ®Google Scholar
• Stashenko P, Jandinski J, Fujiyoshi P, Rynar J, Socransky S. Tissue levels of bone resorptive cytokines in periodontal disease. J Perio. 1991; 62: 504–9.
   PubMed Web of Science ®Google Scholar
• Chiang C, Kyritsis G, Graves D, Amar S. Interleukin-1 and tumor necrosis factor activities partially account for calvarial bone resorption induced by local injection of lipopolysaccharide. Infect Immun. 1999; 67: 4231–6.
   PubMed Web of Science ®Google Scholar
• Koide M, Suda S, Saitoh S, Ofuji Y, Suzuki T, Yoshie H, et al.. In vivo administration of IL-1 beta accelerates silk ligature-induced alveolar bone resorption in rats. J Oral Pathol Med. 1995; 24: 420–34.
   PubMed Web of Science ®Google Scholar
• Dayan S, Stashenko P, Niederman R, Kupper TS. Oral epithelial overexpression of IL-1alpha causes periodontal disease. J Dent Res. 2004; 83: 786–90.
   PubMed Web of Science ®Google Scholar
• Kurtis B, Tuter G, Serdar M, Akdemir P, Uygur C, Firatli E, et al.. Gingival crevicular fluid levels of monocyte chemoattractant protein-1 and tumor necrosis factor-alpha in patients with chronic and aggressive periodontitis. J Periodontol. 2005; 76: 1849–55.
   PubMed Web of Science ®Google Scholar
• Bostrom L, Linder L, Bergstrom J. Clinical expression of TNF-alpha in smoking-associated periodontal disease. J Clin Periodontol. 1998; 25: 767–73.
   PubMed Web of Science ®Google Scholar
• Lee HJ, Kang IK, Chung CP, Choi SM. The subgingival microflora and gingival crevicular fluid cytokines in refractory periodontitis. J Clin Periodontol. 1995; 22: 885–90.
   PubMed Web of Science ®Google Scholar
• Gaspersic R, Stiblar-Martincic D, Osredkar J, Skaleric U. Influence of subcutaneous administration of recombinant TNF-alpha on ligature-induced periodontitis in rats. J Periodontal Res. 2003; 38: 198–203.
   PubMed Web of Science ®Google Scholar
• Graves D, Oskoui M, Volejnikova S, Naguib G, Cai S, Desta T, et al.. Tumor necrosis factor modulates fibroblast apoptosis, PMN recruitment, and osteoclast formation in response to P. gingivalis infection. J Dent Res. 2001; 80: 1875–9.
   PubMed Web of Science ®Google Scholar
• Garlet GP, Cardoso CR, Campanelli AP, Ferreira BR, Avila-Campos MJ, Cunha FQ, et al.. The dual role of p55 tumour necrosis factor-alpha receptor in Actinobacillus actinomycetemcomitans-induced experimental periodontitis: host protection and tissue destruction. Clin Exp Immunol. 2007; 147: 128–38.
   PubMed Web of Science ®Google Scholar
• Liu R, Desta T, Raptis M, Darveau RP, Graves DT. P. gingivalis and E. coli lipopolysaccharides exhibit different systemic but similar local induction of inflammatory markers. J Periodontol. 2008; 79: 1241–7.
   PubMed Web of Science ®Google Scholar
• Graves D, Liu R, Alikhani M, Al-Mashat H, Trackman P. Diabetes-enhanced inflammation and apoptosis – impact on periodontal pathology. J Dent Res. 2006; 85f: 15–21.
   Web of Science ®Google Scholar
• Takeichi O, Haber J, Kawai T, Smith DJ, Moro I, Taubman MA. Cytokine profiles of T-lymphocytes from gingival tissues with pathological pocketing. J Dent Res. 2000; 79: 1548–55.
   PubMed Web of Science ®Google Scholar
• Rogers JE, Li F, Coatney DD, Rossa C, Bronson P, Krieder JM, et al.. Actinobacillus actinomycetemcomitans lipopolysaccharide-mediated experimental bone loss model for aggressive periodontitis. J Periodontol. 2007; 78: 550–8.
   PubMed Web of Science ®Google Scholar
• Page R, Schroeder H. Pathogenesis of inflammatory periodontal disease. A summary of current work. Lab Invest. 1976; 34: 235–49.
   PubMed Web of Science ®Google Scholar
• Aggarwal R, Ghobrial IM, Roodman GD. Chemokines in multiple myeloma. Exp Hematol. 2006; 34: 1289–95.
   PubMed Web of Science ®Google Scholar
• Tsai CC, Ho YP, Chen CC. Levels of interleukin-1 beta and interleukin-8 in gingival crevicular fluids in adult periodontitis. J Periodontol. 1995; 66: 852–9.
   PubMed Web of Science ®Google Scholar
• Gemmell E, Carter CL, Seymour GJ. Chemokines in human periodontal disease tissues. Clin Exp Immunol. 2001; 125: 134–41.
   PubMed Web of Science ®Google Scholar
• Alnaeeli M, Park J, Mahamed D, Penninger JM, Teng YT. Dendritic cells at the osteo-immune interface: implications for inflammation-induced bone loss. J Bone Miner Res. 2007; 22: 775–80.
   Web of Science ®Google Scholar
• Bonecchi R, Galliera E, Borroni EM, Corsi MM, Locati M, Mantovani A. Chemokines and chemokine receptors: an overview. Front Biosci. 2009; 14: 540–51.
   PubMed Web of Science ®Google Scholar
• Zhang X, Teng YT. Interleukin-10 inhibits gram-negative-microbe-specific human receptor activator of NF-kappaB ligand-positive CD4 + -Th1-cell-associated alveolar bone loss in vivo. Infect Immun. 2006; 74: 4927–31.
   PubMed Web of Science ®Google Scholar
• Watanabe T, Kukita T, Kukita A, Wada N, Toh K, Nagata K, et al.. Direct stimulation of osteoclastogenesis by MIP-1alpha: evidence obtained from studies using RAW264 cell clone highly responsive to RANKL. J Endocrinol. 2004; 180: 193–201.
   PubMed Web of Science ®Google Scholar
• Hosokawa Y, Hosokawa I, Ozaki K, Nakae H, Murakami K, Miyake Y, et al.. CXCL12 and CXCR4 expression by human gingival fibroblasts in periodontal disease. Clin Exp Immunol. 2005; 141: 467–74.
   PubMed Web of Science ®Google Scholar
• Gamonal J, Acevedo A, Bascones A, Jorge O, Silva A. Characterization of cellular infiltrate, detection of chemokine receptor CCR5 and interleukin-8 and RANTES chemokines in adult periodontitis. J Periodontal Res. 2001; 36: 194–203.
   Web of Science ®Google Scholar
• Garlet G, Martins W Jr, Ferreira B, Milanezi C, Silva J. Patterns of chemokine and chemokine receptors expression in different forms of human periodontal disease. J Periodontal Res. 2003; 38: 210–7.
   PubMed Web of Science ®Google Scholar
• Hanazawa S, Kawata Y, Takeshita A, Kumada H, Okithu M, Tanaka S, et al.. Expression of monocyte chemoattractant protein 1 (MCP-1) in adult periodontal disease: increased monocyte chemotactic activity in crevicular fluids and induction of MCP-1 expression in gingival tissues. Infect Immun. 1993; 61: 5219–24.
   Web of Science ®Google Scholar
• Yu X, Graves D. Fibroblasts, mononuclear phagocytes and endothelial cells express MCP-1 in inflamed human gingiva. J Periodontol. 1995; 66: 80–8.
   PubMed Web of Science ®Google Scholar
• Kawai T, Matsuyama T, Hosokawa Y, Makihira S, Seki M, Karimbux NY, et al.. B and T lymphocytes are the primary sources of RANKL in the bone resorptive lesion of periodontal disease. Am J Pathol. 2006; 169: 987–98.
   PubMed Web of Science ®Google Scholar
• Teng YT, Mahamed D, Singh B. Gamma interferon positively modulates Actinobacillus actinomycetemcomitans-specific RANKL+ CD4+ Th-cell-mediated alveolar bone destruction in vivo. Infect Immun. 2005; 73: 3453–61.
   Web of Science ®Google Scholar
• Agnello D, Lankford CS, Bream J, Morinobu A, Gadina M, O'Shea JJ, et al.. Cytokines and transcription factors that regulate T helper cell differentiation: new players and new insights. J Clin Immunol. 2003; 23: 147–61.
   PubMed Web of Science ®Google Scholar
• Eastcott JW, Yamashita K, Taubman MA, Harada Y, Smith DJ. Adoptive transfer of cloned T helper cells ameliorates periodontal disease in nude rats. Oral Microbiol Immunol. 1994; 9: 284–9.
   PubMedGoogle Scholar
• Gemmell E, Seymour GJ. Immunoregulatory control of Th1/Th2 cytokine profiles in periodontal disease. Periodontol 2000. 2004; 35: 21–41.
   PubMed Web of Science ®Google Scholar
• Kantarci A, Oyaizu K, Van Dyke TE. Neutrophil-mediated tissue injury in periodontal disease pathogenesis: findings from localized aggressive periodontitis. J Periodontol. 2003; 74: 66–75.
   PubMed Web of Science ®Google Scholar
• Dennison DK, Van Dyke TE. The acute inflammatory response and the role of phagocytic cells in periodontal health and disease. Periodontol 2000. 1997; 14: 54–78.
   Web of Science ®Google Scholar
• Garlet GP, Cardoso CR, Campanelli AP, Garlet TP, Avila-Campos MJ, Cunha FQ, et al.. The essential role of IFN-gamma in the control of lethal Aggregatibacter actinomycetemcomitans infection in mice. Microbes Infect. 2008; 10: 489–96.
   PubMed Web of Science ®Google Scholar
• Lee W, Aitken S, Sodek J, McCulloch CA. Evidence of a direct relationship between neutrophil collagenase activity and periodontal tissue destruction in vivo: role of active enzyme in human periodontitis. J Periodontal Res. 1995; 30: 23–33.
   PubMed Web of Science ®Google Scholar
• Strober W. The multifaceted influence of the mucosal microflora on mucosal dendritic cell responses. Immunity. 2009; 31: 377–88.
   PubMed Web of Science ®Google Scholar
• Vernal R, Leon R, Herrera D, Garcia-Sanz JA, Silva A, Sanz M. Variability in the response of human dendritic cells stimulated with Porphyromonas gingivalis or Aggregatibacter actinomycetemcomitans. J Periodontal Res. 2008; 43: 689–97.
   Web of Science ®Google Scholar
• Jotwani R, Cutler CW. Fimbriated Porphyromonas gingivalis is more efficient than fimbria-deficient P. gingivalis in entering human dendritic cells in vitro and induces an inflammatory Th1 effector response. Infect Immun. 2004; 72: 1725–32.
   PubMed Web of Science ®Google Scholar
• Madianos PN, Bobetsis YA, Kinane DF. Generation of inflammatory stimuli: how bacteria set up inflammatory responses in the gingiva. J Clin Periodontol. 2005; 32: 57–71.
   PubMed Web of Science ®Google Scholar
• Leibbrandt A, Penninger JM. RANK/RANKL: regulators of immune responses and bone physiology. Ann NY Acad Sci. 2008; 1143: 123–50.
   PubMed Web of Science ®Google Scholar
• Alnaeeli M, Penninger JM, Teng YT. Immune interactions with CD4+ T cells promote the development of functional osteoclasts from murine CD11c+ dendritic cells. J Immunol. 2006; 177: 3314–26.
   PubMed Web of Science ®Google Scholar
• Baker P, Evans R, Roopenian D. Oral infection with Porphyromonas gingivalis and induced alveolar bone loss in immunocompetent and severe combined immunodeficient mice. Arch Oral Biol. 1994; 39: 1035–40.
   Web of Science ®Google Scholar
• Miossec P, Korn T, Kuchroo VK. Interleukin-17 and type 17 helper T cells. N Engl J Med. 2009; 361: 888–98.
   PubMed Web of Science ®Google Scholar
• Yu JJ, Ruddy MJ, Wong GC, Sfintescu C, Baker PJ, Smith JB, et al.. An essential role for IL-17 in preventing pathogen-initiated bone destruction: recruitment of neutrophils to inflamed bone requires IL-17 receptor-dependent signals. Blood. 2007; 109: 3794–802.
   PubMed Web of Science ®Google Scholar
• Cardoso CR, Garlet GP, Crippa GE, Rosa AL, Junior WM, Rossi MA, et al.. Evidence of the presence of T helper type 17 cells in chronic lesions of human periodontal disease. Oral Microbiol Immunol. 2009; 24: 1–6.
   PubMedGoogle Scholar
• Vignali DA, Collison LW, Workman CJ. How regulatory T cells work. Nat Rev Immunol. 2008; 8: 523–32.
   PubMed Web of Science ®Google Scholar
• Cardoso CR, Garlet GP, Moreira AP, Junior WM, Rossi MA, Silva JS. Characterization of CD4+ CD25+ natural regulatory T cells in the inflammatory infiltrate of human chronic periodontitis. J Leukoc Biol. 2008; 84: 311–8.
   Web of Science ®Google Scholar
• Ernst CW, Lee JE, Nakanishi T, Karimbux NY, Rezende TM, Stashenko P, et al.. Diminished forkhead box P3/CD25 double-positive T regulatory cells are associated with the increased nuclear factor-kappaB ligand (RANKL + ) T cells in bone resorption lesion of periodontal disease. Clin Exp Immunol. 2007; 148: 271–80.
   Web of Science ®Google Scholar
• Nakajima T, Ueki-Maruyama K, Oda T, Ohsawa Y, Ito H, Seymour GJ, et al.. Regulatory T-cells infiltrate periodontal disease tissues. J Dent Res. 2005; 84: 639–43.
   PubMed Web of Science ®Google Scholar
• Parfitt A. The coupling of bone formation to bone resorption: a critical analysis of the concept and of its relevance to the pathogenesis of osteoporosis. Metab Bone Dis Relat Res. 1982; 4: 1–6.
   PubMedGoogle Scholar
• Behl Y, Siqueira M, Ortiz J, Li J, Desta T, Faibish D, et al.. Activation of the acquired immune response reduces coupled bone formation in response to a periodontal pathogen. J Immunol. 2008; 181: 8711–8.
   PubMed Web of Science ®Google Scholar
• Liu R, Bal HS, Desta T, Krothapalli N, Alyassi M, Luan Q, et al.. Diabetes enhances periodontal bone loss through enhanced resorption and diminished bone formation. J Dent Res. 2006; 85: 510–4.
   PubMed Web of Science ®Google Scholar